Intended Use

The Cionic Neural Sleeve NS-200 is intended to provide ankle dorsiflexion and/or plantarflexion and/or eversion in adult individuals with foot drop and/or to assist knee flexion or extension in adult individuals with muscle weakness related to upper motor neuron disease/injury (e.g. stroke, damage to pathways to the spinal cord). It electrically stimulates muscles in the affected leg and may improve gait, facilitate muscle re-education, prevent atrophy, maintain joint range of motion, and increase local blood flow.

Technology

The device consists of a fabric sleeve with embedded motion sensors and skin-contact electrodes, a portable battery-powered control unit, and a mobile application. It uses embedded surface electromyography (sEMG) sensors to measure muscle electrical activity and motion. The control unit processes these data to generate electrical stimulation to activate muscles for exercise or functional assistance. Advanced biofeedback modes include visual biofeedback and muscle-activated stimulation triggered by sEMG signals.

Performance

The CIONIC Neural Sleeve NS-200 was tested with bench testing including output waveform, isolation, hybrid stimulation, electrical safety (IEC 60601-1 series), electromagnetic compatibility (IEC 60601-1-2), muscle and nerve stimulator standards (IEC 60601-2-10), and software validation (IEC 62304). Usability testing per IEC 62366 and IEC 60601-1-6 was leveraged from predicate devices. Clinical literature supports the new indication of foot eversion stimulation.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/13/2024

    4 months
  • 2

    FDA Approval

    5/2/2025

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.